Seqens opens ‘I&D’ centre
Seqens has officially opened its main innovation and development (I&D) centre called Seqens’Lab at Porcheville, near Paris, with a ribbon-cutting ceremony performed by Agnès Pannier-Runacher, secretary of state to the Minister of Economy & Finance. This covers a space of 34,000 m2. The amount invested in it was not disclosed.
The company describes Seqens’Lab as “a unique ecosystem, dedicated to our customers to accelerate their projects from the early R&D stages to production and sales”. It will be mainly active in the end use markets of pharmaceuticals, cosmetics and speciality ingredients.
SMEs and start-ups specialised in analytical services and CROs will both also be based there. Christophe Eychenne-Baron, R&D director, added that Seqens also wants “to facilitate interactions with our academic partners and create a LabCom with the National Centre for Scientific Research (CNRS) to design and develop highly innovative solutions”.
Key capabilities at Seqens’Lab include: organic chemistry development; laboratories for physics, solid-state chemistry and process safety; kinetic and thermodynamic simulation tools; flow chemistry and other emerging technologies; and large-batch manufacturing for pre-clinical and clinical studies, all to cGMP.